Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREoperative Targeted OnabotulinumtoXina Injection for Abdominal Wall Reconstruction: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07220382 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT07220382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREoperative Targeted OnabotulinumtoXina Injection for Abdominal Wall Reconstruction: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
November 3, 2025
Completion date
December 15, 2029
Enrollment
188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botox injection, hernia, hernia abdominal wall, hernia incisional, hernia incisional ventral, hernia repair with compartment syndrome, hernia surgery